Latest News - Palantir

Top Corporates Hub

Palantir

PLTR | NASDAQ | United States
84
+223
Rank
$57.52B
Market Cap
$2.86B
+$ 0.64B
+28.83%
Revenue
$0.48B
Earnings
4K
+0.3K
+7.12%
Employees
Palantir: Why Michael Burry's Put Buys Should Not Deter Retail Investors

21.08.2026 05:14

Palantir's U.S. commercial business is delivering triple-digit growth, with GAAP net income margins rising. Learn why PLTR stock is a strong buy.

Read More

Palantir: Buy Before The Next Leg Higher

21.08.2026 01:01

Palantir (PLTR) stock Q2 blew past estimates; revenue was +93% and guidance was raised. Read here for a detailed investment analysis.

Read More

Palantir: Why I'm Not Buying This Rally

19.08.2026 12:00

Palantir Technologies Inc. Q2 earnings beat: 12th straight growth quarter, raised guidance, U.S. commercial +149%. Click for this PLTR update.

Read More

Why Wall Street Still Underestimates Palantir

19.08.2026 06:22

Palantir Q2 2026 revenue grew 19% QoQ, with U.S. Commercial sales up 149% YoY and Government revenue up 79% YoY. Learn why PLTR stock is a buy.

Read More

Palantir Technologies (NASDAQ:PLTR) Demonstrates High-Growth Leadership and Momentum

18.08.2026 11:11

Palantir fits CANSLIM criteria with explosive earnings, strong sales growth, solid technicals, and no debt—but valuation and volatility remain key risks.

Read More

7 Information Technology Stocks With Whale Alerts In Today’s Session

17.08.2026 13:35

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner. Traders will

Read More

Palantir: Winning AI Race With AIP And Forward Deployed Engineer Approach

14.08.2026 14:51

Palantir (PLTR) analysis: AIP bootcamps fuel faster revenue growth and higher guidance, but rich valuation, insider selling and overbought charts—read now.

Read More

Palantir: The Bears Are Running Out Of Arguments

14.08.2026 08:03

Palantir (PLTR) Q2: 93% revenue growth, 62% operating margin and record $2.13B pipeline despite 54x sales valuation.

Read More

AI Earnings Split: Accelerating Growers Rewarded, Cloud Bellwether Sells Off

13.08.2026 12:07

AI earnings split: Palantir and AMD surge on strong results, Amazon stumbles—investors now reward visible AI momentum.

Read More

Market Would Fall by 12,152 Points in a ‘Black Monday’ Style Crash. Big Short Investor Says It’s Possible.

13.08.2026 11:18

Michael Burry is still short, still warning of a shock on the scale of 1987, and doing so while the Dow sits near all-time highs and the VIX barely stirs. His reasoning traces back to a single, rarely seen S&P 500 signal he says has only appeared three times since 1999.

Read More

Michael Burry Warns of a 1987-Style Crash. Here Are 2 Index ETFs to Buy Anyway.

13.08.2026 09:20

A 1987 crash looks unlikely, but a dollar-cost averaging strategy still is most investors' best bet.

Read More

PLTU: Palantir Already Soared. Buying It With 2X Leverage Now Is a Different Bet Entirely

13.08.2026 09:01

Palantir has already handed investors an 800% gain over three years, and now a leveraged ETF promises to double every move the stock makes. But the mechanics of daily leverage introduce a hidden force that can quietly destroy returns even when you get the direction right.

Read More

Palantir Technologies (PLTR) Is Up 8.0% After Raising 2026 Revenue Guidance On Stronger Q2 Results

13.08.2026 04:31

In early August 2026, Palantir Technologies reported second-quarter results showing sales of US$1.94 billion and net income of US$1.06 billion, alongside stronger performance for the first half of the year and higher earnings per share than a year earlier. Management also raised full-year 2026 revenue guidance to between US$8.15–US$8.16 billion and reiterated expectations for GAAP profitability each quarter, underscoring confidence that demand for its AI platforms will support continued...

Read More

Inovio Pharmaceuticals Q2 Earnings Call Highlights

13.08.2026 00:03

Inovio Pharmaceuticals (NASDAQ:INO) said the U.S. Food and Drug Administration has completed several key steps in its review of the company’s biologics license application for INO-3107, an investigational treatment for recurrent respiratory papillomatosis, or RRP, while the company continues prepara

Read More

Palantir (PLTR) Q2 2026 Earnings Call Transcript

11.08.2026 01:29

Revenue surged 93% year over year as AI demand accelerated across U.S. markets.

Read More

Why Palantir Stock Skyrocketed This Past Week

10.08.2026 04:15

CEO Alex Karp said the AI titan delivered an "otherworldly" performance in the second quarter.

Read More

Palantir vs. Salesforce: Two Visions of Enterprise AI, One Clear Winner

09.08.2026 14:30

Palantir just posted growth numbers that made Wall Street question its own spreadsheets, while Salesforce quietly handed billions back to shareholders. Picking between them means choosing which version of enterprise AI actually survives contact with reality.

Read More

USA Today Q2 Earnings Call Highlights

09.08.2026 09:03

USA Today (NYSE:TDAY) reported second-quarter 2026 revenue of $536.3 million, down 8.3% from a year earlier, as lower digital advertising revenue and quarter-to-quarter variability in content licensing offset gains in digital-only subscriptions and other digital revenue streams. The company generat

Read More

Palantir: Competition Is For Losers (Rating Upgrade)

09.08.2026 08:38

Palantir raised guidance and US commercial outlook, signaling confidence in sustained acceleration and AI-driven tailwinds. See why I rate PLTR stock a Buy.

Read More

Palantir Is Worth $413 Billion. The $500 Billion Line Sits Almost Exactly at Its Record High.

09.08.2026 01:28

A half-trillion-dollar valuation works out to about $208 a share. Shares have already traded within about 55 cents of it.

Read More